A Study to Determine Dose and Regimen of Durvalumab as Monotherapy or in Combination With Pomalidomide With or Without Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma

Local Institution - 105, New York

Local Institution - 401, Torino

Local Institution - 405, Rozzano (MI)

Local Institution - 102, Baltimore

Local Institution - 403, Pavia

Local Institution - 504, Madrid

Local Institution - 106, Charlotte

Local Institution - 502, Pamplona

Local Institution - 603, Toulouse

Local Institution - 110, Cleveland

Local Institution - 505, Valencia

Local Institution - 107, Milwaukee

Local Institution - 601, Lille

Local Institution - 301, Tübingen

Local Institution - 602, Poitiers

Local Institution - 114, Boston

Local Institution - 108, Boston

Local Institution - 115, Boston

Local Institution - 201, Calgary

Local Institution - 702, Amsterdam

Local Institution - 701, Rotterdam

Local Institution - 501, Barcelona